# Blood Bioavailability of Two Different Doses of a β-alanine Supplement (BIo-β)

> **NCT06214338** · NA · COMPLETED · sponsor: **Universidad Católica San Antonio de Murcia** · enrollment: 12 (actual)

## Conditions studied

- Bioavailability

## Interventions

- **DIETARY_SUPPLEMENT:** Low dose
- **DIETARY_SUPPLEMENT:** High dose

## Key facts

- **NCT ID:** NCT06214338
- **Lead sponsor:** Universidad Católica San Antonio de Murcia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-12
- **Primary completion:** 2024-03-18
- **Final completion:** 2024-04-15
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06214338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06214338, "Blood Bioavailability of Two Different Doses of a β-alanine Supplement (BIo-β)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06214338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*